Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fiji Kava Limited ( (AU:CCO) ) has shared an announcement.
The Calmer Co. International Limited has issued 462,142,865 fully paid ordinary shares to sophisticated and professional investors, using an exemption that allows the placement without a full prospectus disclosure. The company states it is compliant with its financial reporting and continuous disclosure obligations and that there is no undisclosed price-sensitive information, signalling an effort to strengthen its capital base while maintaining regulatory transparency for existing shareholders.
The share issue is expected to expand The Calmer Co.’s funding capacity as it pursues growth in the global market for kava-based and other natural relaxation products. For stakeholders, the move implies potential dilution of existing holdings but also greater financial flexibility to support expansion of its brands and distribution network across key international markets.
The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.
More about Fiji Kava Limited
The Calmer Co. International Limited is a fast-growing beverage company focused on kava and other natural, non-alcoholic products that promote relaxation and sleep. It sells drinking powders, kava shots, concentrates and capsules under the Fiji Kava, Taki Mai and Danodan Hempworks brands through global e-commerce and major retail partners in the U.S., Australia, New Zealand and the Pacific Islands.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.18M
For an in-depth examination of CCO stock, go to TipRanks’ Overview page.

